O'Brien-Fleming spendinf function-Hodag | NWBO Message Board Posts


Northwest Biotherapeutics Inc.

  NWBO website

NWBO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  16752 of 17275  at  9/25/2023 3:02:36 PM  by

exwannabe

The following message was updated on 9/25/2023 3:05:11 PM.

 In response to msg 16748 by  co3aii
view thread

Re: O'Brien-Fleming spendinf function-Hodag

   
Not so. The committee is not a for hire group of consultants.
 The ADCOM is just advisory. It is a way for the FDA to get advice from the medical field and industry outside the FDA.
 
They are not paid (well,  maybe expenses). But they still are nothing more than advisors to discuss the questions the FDA asks them.
 
If NWBO wants to include data from combination trials in any submission, then the FDA might ask an ADCOM about it. If not, there is zero chance the subject is broached.
 
 Regardless, we all know NWBO is not submitting to the FDA for the obvious reason (that they are afraid the FDA will disclose the BS by NWBO).

 

 

 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
16753 Re: O'Brien-Fleming spendinf function-Hodag co3aii 0 9/25/2023 3:39:36 PM




Financial Market Data provided by
.
Loading...